[Translated article] Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patients

OBJECTIVE: To describe the marginal cost and survival of patients treated with tocilizumab in a university hospital under real-life conditions and to evaluate factors that could influence costs and health outcomes will be evaluated. METHODS: Observational, single-center, retrospective study of a coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Molina, A., Alos-Almiñana, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier España, S.L.U. 2023
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794483/
https://www.ncbi.nlm.nih.gov/pubmed/36707309
http://dx.doi.org/10.1016/j.farma.2022.12.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794483/
https://www.ncbi.nlm.nih.gov/pubmed/36707309
http://dx.doi.org/10.1016/j.farma.2022.12.014

Ejemplares similares